Cochrane launches global consultation on drug company sponsorshipBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7423.1068 (Published 06 November 2003) Cite this as: BMJ 2003;327:1068
- Ray Moynihan
The leadership of the international Cochrane Collaboration failed to make a decision on drug company sponsorship at last week's annual conference in Barcelona, opting instead for a complex consultation with its 10 000 members.
Professor Jim Neilson, who co-chairs the collaboration's steering group, told the BMJa discussion paper will be released next month, and a final decision will be made in February. “The members have made it very clear they want to have input into this decision.”
The Cochrane Collaboration (http://www.cochrane.org/) produces systematic reviews of the evidence about healthcare interventions, but its supporters …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial